Patents by Inventor Richard Hutchinson
Richard Hutchinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240122352Abstract: The embodiments relate to a geometric under structure, central and outer hub for a GFN plastic chair base. The geometric shape and dimensions are critical components to the overall strength of the chair base hub and arms when either vertical or rotational forces are applied at the central hub. The central hub is of sufficient thickness to maintain dimensional stability when the forces are applied. The overall geometry and material composition enable the hub area to be constructed with minimal plastic wall thickness while optimizing the physical strength of the article and facilitating high production rate.Type: ApplicationFiled: October 20, 2023Publication date: April 18, 2024Inventors: Thomas A. Hutchinson, JR., Gerald A. Hutchinson, Richard E. Hutchinson
-
Publication number: 20240087200Abstract: Systems, methods, and non-transitory computer-readable media can identify a virtual character being presented to a user within a real-time immersive environment. A first animation to be applied to the virtual character is determined. A nonverbal communication animation to be applied to the virtual character simultaneously with the first animation is determined. The virtual character is animated in real-time based on the first animation and the nonverbal communication animation.Type: ApplicationFiled: November 10, 2023Publication date: March 14, 2024Inventors: Nathaniel Christopher Dirksen, Michael Scott Hutchinson, Eric Richard Darnell, Lawrence David Cutler, Daniel Tomas Steamer, Apostolos Lerios
-
Patent number: 11928740Abstract: A multivariate predictive system processes usage based data that includes a database engine that provides access to a plurality of database management systems that mine diverse sources of usage based data. A digital filter selectively filters data streams that include usage based data. A sampler automatically divides the filtered data into sample groups and stores the sample groups in a memory. The sampler divides the filtered data according to insurance rating variables processed by a processor programmed to underwrite an insurance product and rate that insurance product. Some samplers store the divided filter data in a local memory. A multiplier multiples rating factors preprogrammed with the insurance rating variables with a base rate of insurance to determine an insured's insurance premium.Type: GrantFiled: October 6, 2021Date of Patent: March 12, 2024Assignee: PROGRESSIVE CASUALTY INSURANCE COMPANYInventors: Richard Hutchinson, William Everett, David Pratt, Raymond Ling
-
Patent number: 10223751Abstract: A multivariate predictive system processes usage based data that includes a database engine that provides access to a plurality of database management systems that mine diverse sources of usage based data. A digital filter selectively filters data streams that include usage based data. A sampler automatically divides the filtered data into sample groups and stores the sample groups in a memory. The sampler divides the filtered data according to insurance rating variables processed by a processor programmed to underwrite an insurance product and rate that insurance product. Some samplers store the divided filter data in a local memory. A multiplier multiples rating factors preprogrammed with the insurance rating variables with a base rate of insurance to determine an insured's insurance premium.Type: GrantFiled: February 20, 2015Date of Patent: March 5, 2019Assignee: PROGRESSIVE CASUALTY INSURANCE COMPANYInventors: Richard Hutchinson, William Everett, David Pratt, Raymond Ling
-
Publication number: 20100004234Abstract: Resorcylic acid lactones having a C5-C6 cis double bond and a ketone at C7 and other compounds capable of Michael adduct formation are potent and stable inhibitors of a subset of protein kinases having a specific cysteine residue in the ATP binding site.Type: ApplicationFiled: August 6, 2009Publication date: January 7, 2010Inventors: Daniel V. Santi, Ralph C. Reid, C. Richard Hutchinson, Kurt F. Sundermann, Janice Lau
-
Publication number: 20090111869Abstract: The invention relates to benzoquinone ansamycin analogs useful for the treatment of cancer and other diseases or conditions characterized by undesired cellular proliferation or hyperproliferation. Therapies involving the administration of such benzoquinone ansamycin analogs, optionally in combination with an inhibitor of an HSP90 client protein, are useful to treat cancer and non-cancerous disease conditions.Type: ApplicationFiled: June 18, 2008Publication date: April 30, 2009Applicant: Kosan Biosciences, Inc.Inventors: Daniel SANTI, David C. Myles, Zong-Qiang Tian, C. Richard Hutchinson, Robert Johnson, Yi-Qing Zhou, Li Feng
-
Patent number: 7427493Abstract: Materials and methods to produce modified polyketides are disclosed. The biosynthesis, transfer and regulator genes for various sugars to effectuate polyketide modification are disclosed.Type: GrantFiled: June 30, 2003Date of Patent: September 23, 2008Assignee: Kosan Biosciences IncorporatedInventors: C. Richard Hutchinson, Leonard Katz, Ralph Reid, Zhihao Hu, Hugo Gramajo
-
Patent number: 7405208Abstract: The invention relates to benzoquinone ansamycin analogs useful for the treatment of cancer and other diseases or conditions characterized by undesired cellular proliferation or hyperproliferation. Therapies involving the administration of such benzoquinone ansamycin analogs, optionally in combination with an inhibitor of an HSP90 client protein, are useful to treat cancer and non-cancerous disease conditions.Type: GrantFiled: February 11, 2005Date of Patent: July 29, 2008Assignee: Kosan Biosciences, Inc.Inventors: Daniel Santi, David C. Myles, Zong-Qiang Tian, C. Richard Hutchinson, Robert Johnson, Yi-Qing Zhou, Li Feng
-
Publication number: 20070269855Abstract: The invention relates to recombinant polyketide synthase enzymes, polyketide modifying proteins, and other proteins involved in polyketide biosynthesis or function. The invention provides domains of geldanamycin and herbimycin polyketide synthases, polynucleotides that encode such enzymes, and to host cells in which such encoding polynucleotides can be advantageously expressed.Type: ApplicationFiled: January 16, 2007Publication date: November 22, 2007Inventors: Richard Hutchinson, Ralph Reid, Zhihao Hu, Andreas Rascher, Andreas Schirmer, Robert McDaniel
-
Publication number: 20060226137Abstract: A method and apparatus for feeding wire in a welding system include one or more motors disposed adjacent the wire to drive it. A wire feed motor is also disposed along the wire path, and is closer to the source of wire than the torch, and closer to the source than the one or more motors. The motors may be a pair motors disposed on opposite sides of the wire and move the wire to and away from an arc end of a torch. They preferably reversing the direction of the wire within one process cycle. The or more motors may be a stepper motor, a servo motor, a zero backlash motor, a gearless motor, a planetary drive motor, or a linear actuator (such as a piston), in various embodiments.Type: ApplicationFiled: June 23, 2006Publication date: October 12, 2006Applicant: Illinois Tools Works Inc.Inventors: Gerd Huismann, Peter Heneoke, Richard Hutchinson, Bruce Albrecht
-
Patent number: 6872715Abstract: The invention relates to benzoquinone ansamycin analogs useful for the treatment of cancer and other diseases or conditions characterized by undesired cellular proliferation or hyperproliferation. Therapies involving the administration of such benzoquinone ansamycin analogs, optionally in combination with an inhibitor of an HSP90 client protein, are useful to treat cancer and non-cancerous disease conditions.Type: GrantFiled: August 5, 2002Date of Patent: March 29, 2005Assignee: Kosan Biosciences, Inc.Inventors: Daniel Santi, David C. Myles, Zong-Qiang Tian, C. Richard Hutchinson, Robert Johnson, Yi-Qing Zhou, Li Feng
-
Publication number: 20040203015Abstract: Materials and methods to produce modified polyketides are disclosed. The biosynthesis, transfer and regulator genes for various sugars to effectuate polyketide modification are disclosed.Type: ApplicationFiled: June 30, 2003Publication date: October 14, 2004Inventors: C. Richard Hutchinson, Leonard Katz, Ralph Reid, Zhihao Hu, Hugo Gramajo
-
Publication number: 20040087003Abstract: Described are host cells that contain a polyketide synthase gene and a thioesterase II gene, where the polyketide synthase gene has been modified to prevent utilization of its native starter unit for its expressed polyketide synthase. Also described are host cells containing a polyketide synthase gene and an endogenous thioesterase II gene, where the activity of the endogenous thioesterase II gene product has been decreased or eliminated. Methods for culturing these cells to produce polyketides are also provided, as are the polyketides produced.Type: ApplicationFiled: June 13, 2003Publication date: May 6, 2004Inventors: Zhihao Hu, C. Richard Hutchinson
-
Publication number: 20030114450Abstract: The invention relates to benzoquinone ansamycin analogs useful for the treatment of cancer and other diseases or conditions characterized by undesired cellular proliferation or hyperproliferation. Therapies involving the administration of such benzoquinone ansamycin analogs, optionally in combination with an inhibitor of an HSP90 client protein, are useful to treat cancer and non-cancerous disease conditions.Type: ApplicationFiled: August 5, 2002Publication date: June 19, 2003Inventors: Daniel Santi, David C. Myles, Zong-Qiang Tian, C. Richard Hutchinson, Robert Johnson, Yi-Qing Zhou, Li Feng
-
Publication number: 20030109682Abstract: Cytotoxin-targeting molecule conjugates comprising cytotoxin and an antibody, growth factor, or polysaccharide together with a pH-sensitive or redox potential-sensitive linker. Novel ansamitocins and recombinant genes and organisms that produce them. The use of the described conjugates in the treatment of cancer and other hyperproliferation diseases.Type: ApplicationFiled: September 3, 2002Publication date: June 12, 2003Inventors: Daniel Santi, David C. Myles, Brian Metcalf, C. Richard Hutchinson, Gary Ashley
-
Patent number: 6326591Abstract: A short circuit arc welding system is disclosed. The control scheme uses a current command signal to drive the output current. The command signal is comprised of a long-term current command that sets the long-term current command level and a real-time or short-by-short current command. Arc voltage feedback is used to determine if the desired arc length is present and to adjust the long-term command. The short-by-short current command is derived from real-time arc current feedback and is used to control the burn-off rate by an instantaneous, or short-by-short, adjustment of the current command. A function of the time derivative of arc power, less the time derivative of arc current, is used to detect, in real time, when the short is about to clear. A stop algorithm is employed that monitors the arc on a short-by-short basis. When the process is ending a very low current level is provided to avoid forming a ball.Type: GrantFiled: March 16, 2000Date of Patent: December 4, 2001Assignee: Illinois Tool Works Inc.Inventors: Richard Hutchinson, Todd Holverson, James Uecker
-
Patent number: 6210930Abstract: The present invention is directed to a process for improving daunorubicin and doxorubicin production by means of a recombinant microorganism in which a gene of daunorubicin metabolism is mutated. The mutated gene is preferably dnrU and/or dnrX.Type: GrantFiled: January 14, 1999Date of Patent: April 3, 2001Assignee: Pharmacia & Upjohn, S.P.A.Inventors: Silvia Filippini, Natalia Lomovskaya, Leonid Fonstein, Anna Luisa Colombo, C. Richard Hutchinson, Sharee L. Otten, Umberto Breme
-
Patent number: 5989869Abstract: The present invention is directed to a process for improving daunorubicin and doxorubicin production by means of a recombinant microorganism in which a gene of daunorubicin metabolism involved in the glycosylation of daunorubicin to acid-sensitive, baumycin-like compounds is inactivated.Type: GrantFiled: March 6, 1997Date of Patent: November 23, 1999Assignee: Pharmacia & Upjohn S.p.A.Inventors: Silvia Filippini, Natalia Lomovskaya, Leonid Fonstein, Anna Luisa Colombo, C. Richard Hutchinson
-
Patent number: 5786190Abstract: The ability to convert daunorubicin to doxorubicin can be conferred on a host cell by transformation with a recombinant vector comprising DNA encoding daunorubicin 14-hydroxylase. The host cell can then be used to produce doxorubicin.Type: GrantFiled: December 3, 1996Date of Patent: July 28, 1998Assignee: Pharmacia & Upjohn S.p.A.Inventors: Augusto Solari Inventi, Umberto Breme, Anna Luisa Colombo, Charles Richard Hutchinson, Sharee Otten, Claudio Scotti
-
Patent number: 5695966Abstract: The ability to convert daunorubicin to doxorubicin can be conferred on a host cell by transformation with a recombinant vector comprising DNA encoding daunorubicin 14-hydroxylase. The host cell can then be used to produce doxorubicin.Type: GrantFiled: February 27, 1995Date of Patent: December 9, 1997Assignee: Pharmacia & Upjohn S.p.A.Inventors: Augusto Solari Inventi, Umberto Breme, Anna Luisa Colombo, Charles Richard Hutchinson, Sharee Otten, Claudio Scotti